$THMO
ThermoGenesis Holdings, Inc.

2015 Q3 Form 10-Q Financial Statement

#000143774915020970 Filed on November 16, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q3
Revenue $2.823M $3.655M
YoY Change -22.76% 0.41%
Cost Of Revenue $2.456M $2.469M
YoY Change -0.53% 9.73%
Gross Profit $367.0K $1.186M
YoY Change -69.06% -14.68%
Gross Profit Margin 13.0% 32.45%
Selling, General & Admin $3.184M $2.996M
YoY Change 6.28% 4.76%
% of Gross Profit 867.57% 252.61%
Research & Development $1.097M $1.477M
YoY Change -25.73% 77.95%
% of Gross Profit 298.91% 124.54%
Depreciation & Amortization $365.0K $322.0K
YoY Change 13.35% 101.25%
% of Gross Profit 99.46% 27.15%
Operating Expenses $4.281M $4.473M
YoY Change -4.29% 21.22%
Operating Profit -$3.914M -$3.287M
YoY Change 19.08% 42.91%
Interest Expense $7.000K -$10.00K
YoY Change -170.0%
% of Operating Profit
Other Income/Expense, Net $29.00K $9.000K
YoY Change 222.22%
Pretax Income -$3.400M -$3.300M
YoY Change 3.03% 43.48%
Income Tax
% Of Pretax Income
Net Earnings -$3.397M -$3.296M
YoY Change 3.06% 43.3%
Net Earnings / Revenue -120.33% -90.18%
Basic Earnings Per Share
Diluted Earnings Per Share -$17.00M -$16.50M
COMMON SHARES
Basic Shares Outstanding 40.62M
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.560M $10.71M
YoY Change -38.75% 101.69%
Cash & Equivalents $6.559M $10.71M
Short-Term Investments
Other Short-Term Assets $130.0K $490.0K
YoY Change -73.47% 53.13%
Inventory $3.971M $5.890M
Prepaid Expenses
Receivables $3.648M $4.370M
Other Receivables $0.00 $0.00
Total Short-Term Assets $14.31M $21.46M
YoY Change -33.32% 50.6%
LONG-TERM ASSETS
Property, Plant & Equipment $3.196M $2.580M
YoY Change 23.88% 17.81%
Goodwill $13.20M
YoY Change
Intangibles $21.16M
YoY Change
Long-Term Investments
YoY Change
Other Assets $78.00K $80.00K
YoY Change -2.5% 60.0%
Total Long-Term Assets $37.63M $37.71M
YoY Change -0.22% 1591.03%
TOTAL ASSETS
Total Short-Term Assets $14.31M $21.46M
Total Long-Term Assets $37.63M $37.71M
Total Assets $51.94M $59.17M
YoY Change -12.23% 259.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.650M $3.010M
YoY Change 87.71% -6.52%
Accrued Expenses $620.0K $470.0K
YoY Change 31.91% -22.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.899M $5.680M
YoY Change 56.67% 7.37%
LONG-TERM LIABILITIES
Long-Term Debt $20.00K $0.00
YoY Change
Other Long-Term Liabilities $267.0K $240.0K
YoY Change 11.25% 200.0%
Total Long-Term Liabilities $267.0K $240.0K
YoY Change 11.25% 200.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.899M $5.680M
Total Long-Term Liabilities $267.0K $240.0K
Total Liabilities $19.68M $13.57M
YoY Change 45.01% 153.17%
SHAREHOLDERS EQUITY
Retained Earnings -$141.1M
YoY Change
Common Stock $41.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.26M $45.60M
YoY Change
Total Liabilities & Shareholders Equity $51.94M $59.17M
YoY Change -12.23% 259.04%

Cashflow Statement

Concept 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income -$3.397M -$3.296M
YoY Change 3.06% 43.3%
Depreciation, Depletion And Amortization $365.0K $322.0K
YoY Change 13.35% 101.25%
Cash From Operating Activities -$1.305M -$3.685M
YoY Change -64.59% 167.03%
INVESTING ACTIVITIES
Capital Expenditures $187.0K $339.0K
YoY Change -44.84% -360.77%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$187.0K -$339.0K
YoY Change -44.84% 160.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.000K $55.00K
YoY Change -90.91% -178.57%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.701M -55.00K
YoY Change -8647.27% -21.43%
NET CHANGE
Cash From Operating Activities -1.305M -3.685M
Cash From Investing Activities -187.0K -339.0K
Cash From Financing Activities 4.701M -55.00K
Net Change In Cash 3.209M -4.079M
YoY Change -178.67% 158.16%
FREE CASH FLOW
Cash From Operating Activities -$1.305M -$3.685M
Capital Expenditures $187.0K $339.0K
Free Cash Flow -$1.492M -$4.024M
YoY Change -62.92% 221.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 kool Convertible Debt Gross
ConvertibleDebtGross
5500000
CY2015Q3 kool Derivative Liability Additions
DerivativeLiabilityAdditions
4282000
CY2015Q3 kool Derivative Obligation Related To Issuance Of Warrants
DerivativeObligationRelatedToIssuanceOfWarrants
4282000
CY2014Q3 kool Derivative Obligation Related To Issuance Of Warrants
DerivativeObligationRelatedToIssuanceOfWarrants
CY2015Q3 kool Equipment Acquired By Capital Lease
EquipmentAcquiredByCapitalLease
CY2015Q3 kool Approval For Grant In Amount For Clinical Trial
ApprovalForGrantInAmountForClinicalTrial
10000000
CY2015Q3 kool Cashless Basis Of Class Of Warrant To Be Exercised Number Of Shares To Be Issueduplift Percentage
CashlessBasisOfClassOfWarrantToBeExercisedNumberOfSharesToBeIssuedupliftPercentage
2.5
CY2015Q3 kool Cashless Basis Of Class Of Warrant To Be Exercised Per Share
CashlessBasisOfClassOfWarrantToBeExercisedPerShare
0.10
CY2015Q3 kool Cashless Basisof Class Of Warrant To Be Exercised Weighted Average Price Percentage
CashlessBasisofClassOfWarrantToBeExercisedWeightedAveragePricePercentage
0.9
CY2015Q3 kool Class Of Warrant Or Right Outstanding Intrinsic Value
ClassOfWarrantOrRightOutstandingIntrinsicValue
0
CY2014Q3 kool Equipment Acquired By Capital Lease
EquipmentAcquiredByCapitalLease
112000
CY2015Q3 kool Gross Proceeds From Convertible Debt
GrossProceedsFromConvertibleDebt
5500000
CY2015Q3 kool Maximum Period Of Agreement
MaximumPeriodOfAgreement
P21Y
CY2015Q3 kool Potential Proceed From Issuance Of Convertible Debt
PotentialProceedFromIssuanceOfConvertibleDebt
15000
CY2015Q3 kool Short Term Investment Minimum
ShortTermInvestmentMinimum
2000000
CY2015Q3 kool Working Capital
WorkingCapital
5410000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5650000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5079000
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3648000
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5133000
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5146
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4935
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-30000
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5000
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
173317000
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
172540000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
343000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
284000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
41000
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
46000
CY2015Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
15000
CY2014Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
52068329
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8067005
CY2015Q3 us-gaap Assets
Assets
51935000
CY2015Q2 us-gaap Assets
Assets
50757000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
14309000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
13251000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6559000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3357000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14811000
CY2015 us-gaap Debt Issuance Costs
DebtIssuanceCosts
0
CY2015Q3 us-gaap Debt Issuance Costs
DebtIssuanceCosts
780000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10714000
CY2015Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3202000
CY2014Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4097000
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40653265
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40501730
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40653265
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40501730
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
41000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
41000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3422000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3328000
CY2015Q3 us-gaap Convertible Debt
ConvertibleDebt
15000
CY2015Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
15000
CY2015Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
2456000
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
2469000
CY2015Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4707000
CY2015 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2015 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y146D
CY2015 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.773
CY2015 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.015
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
481000
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
635000
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7641000
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7641000
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
365000
CY2014Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
322000
CY2015Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1426000
CY2015Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
4282000
CY2015Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2015Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2856000
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2015Q3 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-7000
CY2014Q3 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-18000
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
618000
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
705000
CY2014Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3685000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-3397000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-3296000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8899000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7946000
CY2015Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4701000
CY2014Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-55000
CY2015Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-187000
CY2014Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-339000
CY2015Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1305000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2552000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2188000
CY2015Q3 us-gaap Goodwill
Goodwill
13195000
CY2015Q2 us-gaap Goodwill
Goodwill
13195000
CY2015Q3 us-gaap Gross Profit
GrossProfit
367000
CY2014Q3 us-gaap Gross Profit
GrossProfit
1186000
CY2015Q3 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
300000
CY2014Q3 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-571000
CY2015Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1459000
CY2014Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-319000
CY2015Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-134000
CY2014Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-115000
CY2015Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-86000
CY2014Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-131000
CY2015Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-594000
CY2014Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
332000
CY2015Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
CY2014Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3000
CY2015Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
633000
CY2014Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
112000
CY2015Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-29000
CY2014Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
274000
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21157000
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21295000
CY2015Q3 us-gaap Inventory Net
InventoryNet
3971000
CY2015Q2 us-gaap Inventory Net
InventoryNet
4598000
CY2015Q3 us-gaap Liabilities
Liabilities
19678000
CY2015Q2 us-gaap Liabilities
Liabilities
15855000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51935000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50757000
CY2015Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
181000
CY2015Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-21000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
4281000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
4473000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3914000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3287000
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
78000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
79000
CY2015Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-25000
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-32000
CY2015Q3 us-gaap Other Expenses
OtherExpenses
29000
CY2014Q3 us-gaap Other Expenses
OtherExpenses
9000
CY2015Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2150000
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1527000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
267000
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
268000
CY2015Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5000
CY2014Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
55000
CY2015Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
187000
CY2014Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
339000
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
131000
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
163000
CY2015Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4720000
CY2014Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
CY2015Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
627000
CY2015Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
444000
CY2015Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
19000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3196000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2937000
CY2015Q3 us-gaap Registration Payment Arrangement Gains And Losses
RegistrationPaymentArrangementGainsAndLosses
-880000
CY2015Q3 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
14000
CY2014Q3 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1097000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1477000
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-141071000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-137674000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
2823000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
3655000
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
632000
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
808000
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
343000
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
284000
CY2014Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2015Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
32257000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
34902000
CY2015Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
778000
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40552242
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40274711

Files In Submission

Name View Source Status
0001437749-15-020970-index-headers.html Edgar Link pending
0001437749-15-020970-index.html Edgar Link pending
0001437749-15-020970.txt Edgar Link pending
0001437749-15-020970-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kool-20150930.xml Edgar Link completed
kool-20150930.xsd Edgar Link pending
kool-20150930_cal.xml Edgar Link unprocessable
kool-20150930_def.xml Edgar Link unprocessable
kool-20150930_lab.xml Edgar Link unprocessable
kool-20150930_pre.xml Edgar Link unprocessable
kool20150930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending